172 related articles for article (PubMed ID: 7137980)
1. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
[TBL] [Abstract][Full Text] [Related]
2. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
Kawamura S; Sugita R; Fujimaki Y; Deguchi K
Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
[TBL] [Abstract][Full Text] [Related]
6. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of obstetrics and gynecology].
Cho N; Fukunaga K; Kunii K
Jpn J Antibiot; 1983 Mar; 36(3):481-6. PubMed ID: 6876360
[TBL] [Abstract][Full Text] [Related]
7. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
11. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
Schaad UB; Casey PA; Cooper DL
Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Beale AS; Gisby J; Sutherland R
J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
[TBL] [Abstract][Full Text] [Related]
14. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
15. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
Mashimo K
Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
[No Abstract] [Full Text] [Related]
16. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
[TBL] [Abstract][Full Text] [Related]
17. Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.
Boon RJ; Beale AS
Antimicrob Agents Chemother; 1987 Aug; 31(8):1204-9. PubMed ID: 3307617
[TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
[TBL] [Abstract][Full Text] [Related]
19. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagamatsu I; Horiguchi S; Hatae T
Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
